Loading…
Universe Pharmaceuticals INC
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Major managers that reported this stock in their latest 13F.
None of the investors we track reported a position in UPC.
▼ -99.9% over 5Y.
today you would have $0.53▼ -99.9%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
The last 5 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Year-end price | $3.81 | $24.40 | $1,206.00 | $5,220.00 | $5,886.00 | |
| P/E | — | — | — | — | — | 2.7x |
| P/S | 0.0x | 0.0x | 0.0x | 0.0x | 0.8x | 0.7x |
| P/B | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x | 0.8x |
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| TNONTenon Medical, Inc. | $5.00 | — | — | — | -551.19% | $3.34M |
| CALCCalciMedica, Inc. | $0.46 | — | 2.6x | — | -365.70% | $3.17M |
| CLDICalidi Biotherapeutics, Inc. | $1.32 | — | 0.9x | — | -672.22% | $3.41M |
| NXGLNexgel Inc | $0.35 |
Universe Pharmaceuticals INC, through its subsidiaries, engages in the manufacturing, marketing, distribution, and sales of traditional Chinese medicine derivative products in China. The company offers products for the treatment and relief of common chronic health conditions in the elderly for physical wellness and longevity; and cold and flu medications. It also provides guben yanling, shenrong weisheng, and quanlu pill; yangxue danggui and qiangli pipa syrup; wuzi yanzong oral, fengtong medicinal, shenrong medicinal, qishe medicinal, fengshitong medicinal, and shiquan dabu medicinal liquor; paracetamol granule for children; and isatis root granule. In addition, the company distributes and sells third-party products, including biomedical drugs, medical instruments, traditional Chinese medicine pieces, and dietary supplements. It primarily serves pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was founded in 1998 and is headquartered in Ji'An, China. Universe Pharmaceuticals INC is a subsidiary of Sununion Holding Group Limited.
Company description provided by Yahoo Finance.
| EPS | -$8.06 | -$626.96 | -$1,089.21 | -$1,309.11 | $2,148.00 |
| Profit margin | -20.37% | -20.56% | -37.90% | -20.37% | -19.70% | 23.59% |
| ROE | -6.54% | -6.54% | -19.18% | -23.53% | -0.02% | 24.09% |
Median, not average: a single year of near-zero profit produces a P/E of 400 and would drag an average on its own. P/E years above 200x are left out, the same cut the fair price uses — so this median matches the “its own history” method below. Price and EPS have no median: they are series that grow.
| — |
| 0.7x |
| — |
| -115.06% |
| $3.43M |
| PPCBPropanc Biopharma, Inc. | $1.35 | 0.0x | 0.1x | — | -126.98% | $3.08M |
| GNPXGenprex, Inc. | $3.67 | 0.1x | 0.1x | — | -203.86% | $3.01M |